Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health – COPD News Today


Drug Discovery & Development

Propeller Health and Boehringer Ingelheim Collaborate on COPD, Asthma Tools for Better Health
COPD News Today
Boehringer Ingelheim Pharmaceuticals and Propeller Health are partnering to use digital health tools and services to help patients with asthma and chronic obstructive pulmonary disease (COPD) to better cope with their condition. Under the terms of the …
FDA Approves Supplemental New Drug Application (sNDA) for Boehringer Ingelheim's STIOLTO RESPIMAT for COPD PR Newswire (press release)
Boehringer Ingelheim Enters Commercial Partnership with Propeller HealthPharmaceutical Technology Magazine (press release) (blog)

all 3 news articles »

View full post on asthma – Google News

American Lung Association and WellPoint Collaborate to Help Educate About … – Business Wire (press release)

American Lung Association and WellPoint Collaborate to Help Educate About
Business Wire (press release)
According to the Centers for Disease Control and Prevention, asthma is a common, potentially life threatening condition, affecting more than seven million children in the U.S. It is a prevalent issue in our nation's schools. In a typical classroom of

and more »

View full post on asthma – Google News

American Lung Association and WellPoint Collaborate to Help Educate About … – MarketWatch

American Lung Association and WellPoint Collaborate to Help Educate About
MarketWatch
According to the Centers for Disease Control and Prevention, asthma is a common, potentially life threatening condition, affecting more than seven million children in the U.S. It is a prevalent issue in our nation's schools. In a typical classroom of

View full post on asthma – Google News

Children’s Medical, Parkland affiliate collaborate on asthma initiative – Dallas Business Journal (blog)

Children's Medical, Parkland affiliate collaborate on asthma initiative
Dallas Business Journal (blog)
The first project focuses on helping children with chronic asthma, which is the third-leading cause of pediatric hospital re-admissions nationally and a significant cause of admissions and re-admissions at Children's Medical Center. Dallas-based PCCI

View full post on asthma – Google News

Children’s Medical, Parkland collaborate on asthma initiative – Dallas Business Journal (blog)

Children's Medical, Parkland collaborate on asthma initiative
Dallas Business Journal (blog)
The first project focuses on helping children with chronic asthma, which is the third-leading cause of pediatric hospital re-admissions nationally and a significant cause of admissions and re-admissions at Children's Medical Center. Dallas-based PCCI

View full post on asthma – Google News

Ohio’s children’s hospitals to collaborate on asthma and drug-addicted babies … – Plain Dealer

Ohio's children's hospitals to collaborate on asthma and drug-addicted babies
Plain Dealer
By Reginald Fields, The Plain Dealer Cleveland's Rainbow Babies & Children's Hospital is partnering with the state's other five children's hospitals to perform joint research in two areas: childhood asthma and caring for drug-addicted newborns.
Children's hospitals to tackle research projects on low-weight babiesColumbus Dispatch

all 2 news articles »

View full post on asthma – Google News

Scientists collaborate in discovery of new targets for the treatment of asthma – Science Codex

Scientists collaborate in discovery of new targets for the treatment of asthma
Science Codex
The discovery has the potential for new strategies to treat asthma and other allergic diseases. The research findings have just been published in the leading international journal Nature Immunology. The work was performed by Professor Padraic Fallon,

and more »

View full post on asthma – Google News

Scientists collaborate in discovery of new targets for the treatment of asthma – EurekAlert (press release)

Scientists collaborate in discovery of new targets for the treatment of asthma
EurekAlert (press release)
The discovery has the potential for new strategies to treat asthma and other allergic diseases. The research findings have just been published in the leading international journal Nature Immunology. The work was performed by Professor Padraic Fallon,

View full post on asthma – Google News

MediciNova and University of Colorado Boulder Collaborate on Potential Novel … – MarketWatch (press release)

MediciNova and University of Colorado Boulder Collaborate on Potential Novel
MarketWatch (press release)
Ibudilast has been used in asthma and post-stroke disorders in Japan for around 20 years. MediciNova has demonstrated utility of ibudilast in neurological disorders at higher doses with encouraging outcomes in company-sponsored clinical trials in

and more »

View full post on asthma – Google News